Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A clinician's guide to statin drug-drug interactions.

Journal of clinical lipidology - 1 Jan 2000

Kellick Kenneth A, Bottorff Michael, Toth Peter P, The National Lipid Association's Safety Task Force

Abstract excerpt

The statins are widely used worldwide to reduce risk for cardiovascular events in both the primary and secondary prevention settings. Although generally quite safe, the statins can be associated with a variety of serious side adverse effects, including myalgia, myopathy, and changes in plasma enzymes of hepatic origin. Although rare, the most serious of these is rhabdomyolysis. Several drugs can interfere with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily G, Member 2
Share to Drug Interactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Evidence-Based Medicine

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Liver-Specific Organic Anion Transporter 1

Share to Muscular Diseases

Share to Myalgia

Share to Organic Anion Transporters

Source

Identifiers

PMID: 24793440
DOI: 10.1016/j.jacl.2014.02.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A clinician's guide to statin drug-drug interactions.PMID 24793440Read ↗

Clinical implications of pharmacogenetic variation on the effects of statins.Semantic proximity Read ↗

Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.Semantic proximity Read ↗

Approach to clinical and genetic characterization of statin-induced myopathy.Semantic proximity Read ↗

Liver and Statins: A Critical Appraisal of the Evidence.Semantic proximity Read ↗

Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle ComponentsSemantic proximity Read ↗

[Statin-induced adverse effects -- facts and genes].Semantic proximity Read ↗

Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy.Semantic proximity Read ↗

Statin-associated myopathy: from genetic predisposition to clinical management.Semantic proximity Read ↗

Non-cardiovascular effects associated with statins.Semantic proximity Read ↗

Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.Semantic proximity Read ↗

Pharmacogenetics of Statin-Induced MyotoxicitySemantic proximity Read ↗

Pharmacogenomics, lipid disorders, and treatment options.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.